Keywords: amgen, forecasts, rise, profits, boosted, lead, drugs

Amgen forecasts 18%-30% rise in 2004 profits, boosted by lead drugs

Article | 22 December 2003

Print This

Global biotechnology leader Amgen has forecast a rise of 18%-30% in its2004 profits but still saw its share price drop 1.9% ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in